DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF NIRAPARIB AND ABIRATERONE IN PHARMACEUTICAL DOSAGE FORMS

Authors

  • Vasuri Sravani
  • Dr. K. Shravan Kumar
  • Dr. K. Chaitanya Prasad
  • Dr. K. Shravan Kumar

Keywords:

RP-HPLC,

Abstract

A novel, robust, and stability-indicating reverse-phase high-performance liquid
chromatography (RP-HPLC) method was developed and validated for the simultaneous estimation
of niraparib and abiraterone in pharmaceutical dosage forms.

Downloads

Published

2026-03-21

How to Cite

Vasuri Sravani, Dr. K. Shravan Kumar, Dr. K. Chaitanya Prasad, & Dr. K. Shravan Kumar. (2026). DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF NIRAPARIB AND ABIRATERONE IN PHARMACEUTICAL DOSAGE FORMS. The Bioscan, 21(Special Issue-1), 909–920. Retrieved from https://thebioscan.com/index.php/pub/article/view/5388

Issue

Vol. 21 No. Special Issue-1 (2026): Volume 21 Special Issue 1 Jan-Mar (2026)

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.